Drug-induced hyperthermic syndromes. Part I. Hyperthermia in overdose

Emergency Medicine Clinics of North America

Volumn 31, Issue 4, 2013, Pages 1019-1033

  Hayes, Bryan D ^a,b   Martinez, Joseph P ^a   Barrueto, Fermin ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Upper Chesapeake Health   (United States)

Author keywords

Anticholinergics; Cocaine; Hypermetabolism; Hyperthermia; Methlenedioxymethamphetamine; Salicylates; Sympathomimetics; Thermoregulatory system

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; DATURA STRAMONIUM EXTRACT; DIAZEPAM; DIMENHYDRINATE; DIPHENHYDRAMINE; EPHEDRINE; ERGOT ALKALOID; HYDROXYZINE; MIDAZOLAM; MIDODRINE; OLANZAPINE; OXYBUTYNIN; PHENCYCLIDINE; PHENOTHIAZINE DERIVATIVE; PHENTOLAMINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PROMETHAZINE; PSEUDOEPHEDRINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VECURONIUM;

ADRENERGIC SYSTEM; ANTICHOLINERGIC SYNDROME; BODY TEMPERATURE DISORDER; COOLING; DIAPHORESIS; DOPAMINERGIC SYSTEM; DRUG OVERDOSE; DRY SKIN; EMERGENCY PHYSICIAN; ENVIRONMENTAL TEMPERATURE; EUPHORIA; EYE DISEASE; GASTROINTESTINAL DISEASE; HALLUCINATION; HUMAN; HYPERMETABOLISM; HYPERTENSION; HYPERTHERMIA; HYPOTHALAMUS; LUNG DISEASE; NEGATIVE FEEDBACK; NOCICEPTION; ORAL MUCOSAL DISEASE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; QRS COMPLEX; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; TACHYCARDIA; THERMOGENESIS; THERMOREGULATION; URINE RETENTION; VASOCONSTRICTION;

ANTICHOLINERGICS; COCAINE; HYPERMETABOLISM; HYPERTHERMIA; METHLENEDIOXYMETHAMPHETAMINE; SALICYLATES; SYMPATHOMIMETICS; THERMOREGULATORY SYSTEM;

CHOLINERGIC ANTAGONISTS; DRUG OVERDOSE; FEVER; HUMANS; SEIZURES; SYMPATHOMIMETICS; XENOBIOTICS;

EID: 84886600475     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.emc.2013.07.004     Document Type: Review

References (80)

1. Sithinamsuwan P., Piyavechviratana K., Kitthaweesin T., et al. Exertional heatstroke: early recognition and outcome with aggressive combined cooling: a 12 year experience. Mil Med 2009, 174:496-502.
2. Clapham J.C. Central control of thermogenesis. Neuropharmacology 2012, 63:111-123.
3. Boulant J.A. Hypothalamic neurons: mechanisms of sensitivity to temperature. Ann N Y Acad Sci 1998, 856:108-115.
4. Dinarello C.A., Porat R. Harrison's principles of internal medicine 2011, 142. McGraw-Hill, New York. 18th edition.
5. Rowell L.B. Cardiovascular aspects of human thermoregulation. Circ Res 1983, 52:367-379.
6. Hensel H. Neural processes in thermoregulation. Physiol Rev 1973, 53:948-1017.
7. Durnas C., Cusack B.J. Salicylate intoxication in the elderly: recognition and recommendations on how to prevent it. Drugs Aging 1992, 2:20-34.
8. Majlesi N., Greller H.A., McGuigan M.A. Thyroid storm after pediatric levothyroxine ingestion. Pediatrics 2010, 126(2):e470-e473.
9. Marom T., Itskoviz D., Lavon H., et al. Acute care for exercise-induced hyperthermia to avoid adverse outcome from exertional heat stroke. JSport Rehabil 2011, 20:219-227.
10. Lanner J.T. Ryanodine receptor physiology and its role in disease. Adv Exp Med Biol 2012, 740:217-234.
11. Hirshey Dirksen S.J., Larach M.G., Rosenber H., et al. Special article: future directions in malignant hyperthermia research and patient care. Anesth Analg 2011, 113:1108-1119.
12. Perry P.J., Wilborn C.A. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses and management. Ann Clin Psychiatry 2012, 24:155-162.
13. Docherty J.R. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 1998, 361:1-15.
14. Insel P.A. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors-evolving concepts and clinical implications. NEngl J Med 1996, 334:580-585.
15. Meggs W.J. Epidemics of mold poisoning past and present. Toxicol Ind Health 2009, 25:571-576.
16. Kiyatkin E.A., Sharma H.S. Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema and morphological cell abnormalities. Int Rev Neurobiol 2009, 88:65-100.
17. Sharma H.S., Muresanu D., Sharma A., et al. Cocaine induced breakdown of the blood-brain barrier and neurotoxcity. Int Rev Neurobiol 2009, 88:297-334.
18. Armen R., Kanel G., Reynolds T. Phencyclidine-induced malignant hyperthermia causing submassive liver necrosis. Am J Med 1984, 77:167-172.
19. Parrott A.C. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans. Drug Alcohol Depend 2012, 121:1-9.
20. Bohnert A.S., Prescott M.R., Vlahov D., et al. Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006. Addiction 2010, 105:1049-1054.
21. Traub S.J., Hoffman R.S., Nelson L.S. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine. JUrban Health 2002, 79(4):549-555.
22. Sexton R.L., Carlson R.G., Leukefeld C.G., et al. "Tweaking and geeking, just having some fun": an analysis of methamphetamine poems. JPsychoactive Drugs 2010, 42:377-383.
23. Ross E.A., Watson M., Goldberger B. "Bath salts" intoxication. NEngl J Med 2011, 365:967-968.
24. Hoffman R.S. Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside. Br J Clin Pharmacol 2010, 69:448-457.
25. Burke S., Hanani M. The actions of hyperthermia on the autonomic nervous: central and peripheral mechanisms and clinical implications. Auton Neurosci 2012, 168:4-13.
26. Holzer M. Targeted temperature management for comatose survivors of cardiac arrest. NEngl J Med 2010, 363:1256-1264.
27. Howes D., Ohley W., Dorian P., et al. Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. Resuscitation 2010, 81:388-392.
28. Lazarus A. Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics. Gen Hosp Psychiatry 1985, 7:361-363.
29. Pitts W.R., Vongpatanasin W., Cigarroa J.E., et al. Effects of intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans. Circulation 1998, 97:1270-1273.
30. De Giorgi A., Fabbian F., Pala M., et al. Cocaine and acute vascular disease. Curr Drug Abuse Rev 2012, 5:129-134.
31. Lewin L. Phantastica: narcotic and stimulating drugs 1964, Dutton, New York.
32. Beverley R. Book II: of the natural product and conveniencies in its Unimprov'd state, before the English went thither 2006, 24. The History and Present State of Virginia, In Four Parts, University of North Carolina, Chapel Hill (NC).
33. Bronstein A.C., Spyker D.A., Cantilena L.R., et al. 2010 annual report of the American Association of Poison Control Centers' national poison data system (NPDS): 28th annual report. Clin Toxicol 2011, 49:910-941.
34. Dubin W.R., Feld J.A. Rapid tranquilization of the violent patient. Am J Emerg Med 1989, 7:313.
35. Weiner A.L., Bayer M.J., McKay C.A., et al. Anticholinergic poisoning with adulterated intranasal cocaine. Am J Emerg Med 1998, 16:517-520.
36. Schneir A.B., Offerman S.R., Ly B.T., et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med 2003, 42:14-19.
37. Pentel P., Peterson C.D. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980, 9:588-590.
38. Burns M.J., Linden C.H., Graudins A., et al. Acomparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 2000, 35:374-381.
39. Suchard J. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. JEmerg Med 2003, 25:185-191.
40. Wallace K.B., Starkov A.A. Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 2000, 40:353-388.
41. Brody T.M. The uncoupling of oxidative phosphorylation as a mechanism of drug action. Pharmacol Rev 1955, 7:335-363.
42. Pec J., Strmenova M., Palencarova E. Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis 1992, 50:307-309.
43. Pei Y.P., Thompson D.A. Severe salicylate intoxication mimicking septic shock. Am J Med 1987, 82:381-382. [letter].
44. Leatherman J.W., Schmitz P.G. Fever, hyperdynamic shock, and multiple-system organ failure: a pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 1991, 100:1391-1396.
45. Thisted B., Krantz T., Strom J. Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesthesiol Scand 1987, 31:312-316.
46. Fisher C.J., Albertson T.E., Foulke G.E. Salicylate-induced pulmonary edema: clinical characteristics in children. Am J Emerg Med 1985, 3:33-37.
47. Schlegel R.J., Altstatt L.B., Canales L. Peritoneal dialysis for severe salicylism: an evaluation of indications and results. JPediatr 1966, 69:553-562.
48. Levy R.I. Overwhelming salicylate intoxication in an adult. Arch Intern Med 1967, 119:399-402.
49. Robin E.D., Davis R.P., Rees S.B. Salicylate intoxication with special reference to the development of hypokalemia. Am J Med 1959, 26:869-882.
50. Candy J.M., Morrison C., Paton R.D. Salicylate toxicity masquerading as malignant hyperthermia. Paediatr Anaesth 1998, 8:421-423.
51. Tainter M.L., Stockton A.B., Cutting W.C. Dinitrophenol in the treatment of obesity. JAMA 1935, 105:332-337.
52. Cutting W.C., Mehrtens H.G., Tainter M.L. Actions and uses of dinitrophenol. JAMA 1933, 101:195.
53. Grundlingh J., Dargan P.I., El-Zanfaly M., et al. 2,4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. JMed Toxicol 2011, 7(3):205-212.
54. Miranda E.J., McIntyre I.M., Parker D.R., et al. Two deaths attributed to the use of 2,4-dinitrophenol. JAnal Toxicol 2006, 30:219-222.
55. McFee R.B., Caraccio T.R., McGuigan M.A., et al. Dying to be thin: a dinitrophenol related fatality. Vet Hum Toxicol 2004, 46:251-254.
56. Macnab A.J., Fielden S.J. Successful treatment of dinitrophenol poisoning in a child. Pediatr Emerg Care 1998, 14:136-138.
57. Bidstrup P.L., Payne D.J. Dinitro-ortho-cresol: report of eight fatal cases occurring in Great Britain. Br Med J 1951, 2:16-19.
58. MacBryde C.M., Taussig B.L. Functional changes in liver, heart and muscles, and loss of dextrose tolerance. JAMA 1935, 105:13-17.
59. Barker K., Seger D., Kumar S. Comment on "Pediatric fatality following ingestion of Dinitrophenol: postmortem identification of a 'dietary supplement". Clin Toxicol (Phila) 2006, 44:351.
60. Vanderpump M.P., Tunbridge W.M., French J.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43:55-68.
61. Leonard J.L., Visser T.J. Biochemistry of iodination. Thyroid hormone metabolism 1986, 189-230. Marcel Dekker, New York. G. Hennemann (Ed.).
62. Hack J.B., John A.L., Nelson L.S., et al. Severe symptoms following massive intentional L-thyroxine ingestion. Vet Hum Toxicol 1999, 41:323-326.
63. Sola E., Gomez-Balaguer M., Morillas C. Massive triiodothyronine intoxication: efficacy of hemoperfusion?. Thyroid 2002, 12:637-640.
64. Jonare A., Munkhammar P., Persson H. Acase of severe levothyroxine poisoning in a child. Clin Toxicol 2001, 39:304-305. [abstract].
65. Brown R.S., Cohen J.H., Braverman L.E. Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid. JPediatr 1998, 132:903-905.
66. Tunget C.L., Clark R.F., Turchen S.G. Raising the decontamination level for thyroid hormone ingestions. Am J Emerg Med 1995, 13:9-13.
67. Berkner P.D., Starkman H., Person N. Acute L-thyroxine overdose; therapy with sodium ipodate: evaluation of clinical and physiologic parameters. JEmerg Med 1991, 9:129-131.
68. Funderburk S.J., Spaulding J.S. Sodium levothyroxine (Synthroid(R)) intoxication in a child. Pediatrics 1970, 45:298-301.
69. Botella de Maglia J., Torrero L.C., Sanchez A.R., et al. Intoxicacion por triyodotironina. Estudio clinco y farmacocinetico. An Med Interna 2003, 20:627-629.
70. Perrin C., Debruyne D., Lacotte J. Treatment of caffeine intoxication by exchange transfusion in a newborn. Acta Paediatr Scand 1987, 76:679-681.
71. Higgins R.M., Hearing S., Goldsmith D.J. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?. Postgrad Med J 1995, 71:224-226.
72. Parr M.J., Willatts S.M. Fatal theophylline poisoning with rhabdomyolysis. Anaesthesia 1991, 46:557-559.
73. Rivenes S.M., Bakerman P.R., Miller M.B. Intentional caffeine poisoning in an infant. Pediatrics 1997, 99:736-738.
74. Lopez-Contreras J., Ruiz D., Domingo P. Isoniazid-induced toxic fever. Rev Infect Dis 1991, 13:775. [letter].
75. Shah B.R., Santucci K., Sinert R. Acute isoniazid neurotoxicity in an urban hospital. Pediatrics 1995, 95:700-704.
76. Makarovsky I., Markel G., Hoffman A., et al. Strychnine-a killer from the past. Isr Med Assoc J 2008, 10:142-145.
77. Oberpaur B., Donoso A., Claveria C. Strychnine poisoning: an uncommon intoxication in children. Pediatr Emerg Care 1999, 15:264-265.
78. Dittrich K., Bayer M.J., Wanke L.A. Acase of fatal strychnine poisoning. JEmerg Med 1984, 1:327-330.
79. Edmunds M., Sheehan T.M., Van't Hoff W. Strychnine poisoning: clinical and toxicological observations on a non-fatal case. JToxicol Clin Toxicol 1986, 24:245-255.
80. Boyd R.E., Brennan P.T., Deng J.F., et al. Strychnine poisoning: recovery from profound lactic acidosis, hyperthermia, and rhabdomyolysis. Am J Med 1983, 74:507-512.